Author contributions Conceptualisation: AB, AW
A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury
This dual pathway therapy brings together two mechanisms in one medication and is offered as a compounded prescription for eligible patients, supporting a more modern, clinician guided approach to individualized metabolic care
The Superpower: It acts like a "Road Crew," building new blood vessels ( angiogenesis ) to speed up healing
High prevalence, recurring symptoms, and concerns linked to long-term pain medication use have increased interest in affordable options with a favorable short-term safety profile
The potential of natural products in PD treatment and their challenges The significant limitations of current PD pharmacological therapies have sparked growing interest in natural products as alternative or adjunctive therapies